(Q48032839)

7 February 2018

title

Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages (English)

1 reference

7 February 2018

1 reference

Takashi Ichiyama

1

1 reference

7 February 2018

Yoshiko Ueno

2

1 reference

7 February 2018

Masanari Hasegawa

3

1 reference

7 February 2018

Akihiro Niimi

4

1 reference

7 February 2018

Tomoyo Matsubara

5

1 reference

7 February 2018

Susumu Furukawa

6

1 reference

7 February 2018

publication date

25 February 2004

1 reference

7 February 2018

Naunyn-Schmiedeberg's Archives of Pharmacology

published in

1 reference

7 February 2018

volume

369

1 reference

7 February 2018

issue

4

1 reference

7 February 2018

page(s)

428-433

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00210-004-0877-x

exact match

0 references

cites work

NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease

1 reference

12 December 2020

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

12 December 2020

Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation

1 reference

12 December 2020

Function and activation of NF-kappa B in the immune system

1 reference

12 December 2020

Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells

1 reference

12 December 2020

Immunology. Giving inhibitory receptors a boost

1 reference

12 December 2020

Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B

1 reference

12 December 2020

An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro

1 reference

12 December 2020

High-dose intravenous gammaglobulin for Kawasaki disease

1 reference

12 December 2020

Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin

1 reference

12 December 2020

Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease

1 reference

12 December 2020

Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity.

1 reference

12 December 2020

CD14+CD16+ monocyte subpopulation in Kawasaki disease

1 reference

12 December 2020

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

12 December 2020

An essential role for NF-kappaB in human CD34(+) bone marrow cell survival.

1 reference

12 December 2020

Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.

1 reference

12 December 2020

Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells

1 reference

12 December 2020

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

12 December 2020

Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease

1 reference

12 December 2020

Pathology of the heart in Kawasaki disease

1 reference

12 December 2020

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor

1 reference

12 December 2020

Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease

1 reference

12 December 2020

Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients

1 reference

12 December 2020

Maturation of macrophages from peripheral blood monocytes in Kawasaki disease: immunocytochemical and immunoelectron microscopic study

1 reference

12 December 2020

Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6.

1 reference

12 December 2020

In vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins

1 reference

12 December 2020

Spontaneous tumor necrosis factor production in Kawasaki disease

1 reference

12 December 2020

Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8

1 reference

12 December 2020

Human intravenous immunoglobulin modulates monokine production in vitro.

1 reference

12 December 2020

Mononuclear cell subsets and coronary artery lesions in Kawasaki disease

1 reference

12 December 2020

Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin

1 reference

12 December 2020

The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits

1 reference

12 December 2020

Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum

1 reference

12 December 2020

Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop

1 reference

12 December 2020

Circulating interleukin-1 beta in patients with Kawasaki disease

1 reference

12 December 2020

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B

1 reference

12 December 2020

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease

1 reference

12 December 2020

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease

1 reference

12 December 2020

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease

1 reference

12 December 2020

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

1 reference

12 December 2020

Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages

1 reference

12 December 2020

Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease

1 reference

12 December 2020

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

1 reference

12 December 2020

10.1007/S00210-004-0877-X

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018